INDOLENT LYMPHOMA

Clinical trials for INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New hope for rare blood cancer: pacritinib trial opens

Disease control Recruiting now

This study tests a drug called pacritinib in 30 people with Waldenström macroglobulinemia whose cancer returned or did not respond to prior treatment. The goal is to see if the drug can shrink tumors and improve symptoms. Participants take the drug by mouth and are monitored for …

Matched conditions: INDOLENT LYMPHOMA

Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control

Last updated May 13, 2026 15:58 UTC

INDOLENT LYMPHOMA

Get alerted when new INDOLENT LYMPHOMA trials appear

New hope for rare blood cancer: pacritinib trial opens